学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Detection of adverse events: what are the current sensitivity limits during clinical development?
被引:14
作者
:
Fritzell, B
论文数:
0
引用数:
0
h-index:
0
机构:
Wyeth Lederle Vaccines, F-92031 Paris, France
Wyeth Lederle Vaccines, F-92031 Paris, France
Fritzell, B
[
1
]
机构
:
[1]
Wyeth Lederle Vaccines, F-92031 Paris, France
来源
:
VACCINE
|
2001年
/ 20卷
关键词
:
D O I
:
10.1016/S0264-410X(01)00291-2
中图分类号
:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号
:
100102 ;
摘要
:
引用
收藏
页码:S47 / S48
页数:2
相关论文
共 2 条
[1]
[Anonymous], N ENGL J MED
[2]
Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study
[J].
Jacobson, RM
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Jacobson, RM
;
Adegbenro, A
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Adegbenro, A
;
Pankratz, VS
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Pankratz, VS
;
Poland, GA
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Poland, GA
.
VACCINE,
2001,
19
(17-19)
:2428
-2433
←
1
→
共 2 条
[1]
[Anonymous], N ENGL J MED
[2]
Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study
[J].
Jacobson, RM
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Jacobson, RM
;
Adegbenro, A
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Adegbenro, A
;
Pankratz, VS
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Pankratz, VS
;
Poland, GA
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Vaccine Res Grp, Rochester, MN 55905 USA
Poland, GA
.
VACCINE,
2001,
19
(17-19)
:2428
-2433
←
1
→